| Literature DB >> 29764503 |
Nikita Singh Yadav1, Saroj Sharma2, Dhiraj Kumar Chaudhary3, Prabhat Panthi4, Pankaj Pokhrel4, Anil Shrestha5, Pappu Kumar Mandal6.
Abstract
OBJECTIVE: Neonatal sepsis is a major cause of morbidity and mortality of newborns (< 1 month of age). Septicemia and drug resistance is a predominant issue for neonatal death in Nepal. This study is intended to find bacteriological profile of neonatal sepsis and antibiotic susceptibility pattern of the isolates from neonates at Kanti Children's Hospital, Kathmandu, Nepal.Entities:
Keywords: Antibiotic susceptibility; Bacteriological profile; Neonatal sepsis; Neonates
Mesh:
Substances:
Year: 2018 PMID: 29764503 PMCID: PMC5952417 DOI: 10.1186/s13104-018-3394-6
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Bacteriological profile of neonatal sepsis from suspected neonates
Prevalence of positive blood culture in relation to different neonatal risk factors
| S. no. | Neonatal risk factors | Culture positive (%) | Culture negative (%) | p value |
|---|---|---|---|---|
| 1 | Sex | > 0.05 | ||
| Male | 31 (52.3) | 173 (59.5) | ||
| Female | 28 (47.4) | 118 (40.5) | ||
| 2 | Age | < 0.05 | ||
| Below 3 days | 17 (28.8) | 35 (12.0) | ||
| 3 or above 3 days | 42 (71.2) | 256 (88.0) | ||
| 3 | Birth weight | < 0.05 | ||
| Very low birth weight | 2 (3.9) | 1 (0.3) | ||
| Low birth wight | 37 (62.7) | 50 (17.2) | ||
| Good birth weight | 20 (33.9) | 240 (82.5) | ||
| 4 | Gestational age | < 0.05 | ||
| Preterm | 22 (31.4) | 48 (68.6) | ||
| Term | 37 (13.2) | 243 (86.7) | ||
| 5 | Mode of delivery | < 0.05 | ||
| Normal | 21 (7.2) | 269 (92.3) | ||
| Caesarean | 38 (63.3) | 22 (36.7) | ||
Antimicrobial susceptibility patterns of bacterial strains isolated from suspected cases of neonatal sepsis
| Antibiotics | CoNS n = 6 (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Ampicillin | 0 | 0 | NT | NT | 2 (50) | 0 | 0 | 5 (24) | 1 (17) |
| Amoxycillin | 5 (36) | 2 (29) | 0 | 0 | 0 | 0 | 1 (100) | 16 (76) | 3 (50) |
| Piperacillin | NT | 7 (100) | NT | 4 (100) | NT | NT | NT | NT | NT |
| Amikacin | 9 (100) | 4 (57) | 6 (100) | 2 (50) | 4 (100) | 1 (100) | 1 (100) | 18 (86) | 6 (100) |
| Gentamicin | 9 (100) | 3 (43) | 6 (100) | 3 (75) | 4 (100) | 1 (100) | 1 (100) | 19 (90) | 6 (100) |
| Azithromycin | NT | NT | NT | NT | NT | NT | 1 (100) | NT | NT |
| Cefotaxime | 0 | 3 (43) | 1 (17) | 2 (50) | 2 (50) | 0 | 1 (100) | 12 (57) | 5 (83) |
| Ceftazidime | 0 | 1 (14) | 2 (33) | 2 (50) | 2 (50) | 1 (100) | 1 (100) | NT | NT |
| Ciprofloxacin | 5 (56) | 1 (14) | 1 (17) | 2 (50) | 3 (75) | 0 | 1 (100) | 18 (86) | 1 (17) |
| Ofloxacin | 7 (78) | 4 (57) | 5 (83) | 3 (75) | 4 (100) | 1 (100) | 1 (100) | 19 (90) | 4 (67) |
| Cotrimoxazole | 1 (11) | 5 (71) | 5 (83) | 0 | 3 (75) | 0 | 0 | NT | NT |
| Erythromycin | NT | NT | NT | NT | NT | NT | NT | 9 (43) | 5 (83) |
| Meropenem | 9 (100) | NT | 6 (100) | NT | NT | 1 (100) | NT | NT | NT |
| Imipenem | 9 (100) | NT | 6 (100) | NT | NT | 1 (100) | NT | NT | NT |